175 related articles for article (PubMed ID: 35877187)
1. Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors.
Spigariolo CB; Barei F; Maronese CA; Barberi F; Cattaneo A; Violetti SA
Australas J Dermatol; 2022 Nov; 63(4):509-512. PubMed ID: 35877187
[TBL] [Abstract][Full Text] [Related]
2. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
Winnicki M; Shear NH
Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
[TBL] [Abstract][Full Text] [Related]
3.
Cabrera Hernandez V; Gonzalez Afonso M; Callero Viera A; Martin-Fernandez Martin L
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31377719
[TBL] [Abstract][Full Text] [Related]
4. Lenalidomide-induced symmetrical drug-related intertriginous and flexural exanthema.
Patel RT; Quan EY; Eikenberg JD; Grider DJ; Phillips MA
Dermatol Online J; 2023 Aug; 29(4):. PubMed ID: 37921816
[TBL] [Abstract][Full Text] [Related]
5. Symmetrical drug-related intertriginous and flexural exanthema/baboon syndrome induced by traditional Chinese medicine.
Liu J; Li LF
J Cosmet Dermatol; 2022 May; 21(5):2200-2204. PubMed ID: 34333850
[TBL] [Abstract][Full Text] [Related]
6. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?
Häusermann P; Harr T; Bircher AJ
Contact Dermatitis; 2004; 51(5-6):297-310. PubMed ID: 15606657
[TBL] [Abstract][Full Text] [Related]
7. Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) associated with Infliximab: a case-based review.
Keshavamurthy C; Fibeger E; Virata A; Bansal P
ARP Rheumatol; 2022; 1(4):322-327. PubMed ID: 36617314
[TBL] [Abstract][Full Text] [Related]
8. Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature.
Schuler AM; Smith EH; Chaudet KM; Bresler SC; Gudjonsson JE; Kroshinsky D; Nazarian RM; Chan MP
J Cutan Pathol; 2021 Dec; 48(12):1471-1479. PubMed ID: 34159622
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing.
Hampel A; Kinaciyan T
Contact Dermatitis; 2024 May; 90(5):525-527. PubMed ID: 38263696
[No Abstract] [Full Text] [Related]
10. Baboon syndrome and toxic erythema of chemotherapy: Fold (intertriginous) dermatoses.
Wolf R; Tüzün Y
Clin Dermatol; 2015; 33(4):462-5. PubMed ID: 26051062
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid.
Cohen PR
Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437156
[TBL] [Abstract][Full Text] [Related]
12. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by telmisartan-hydrochlorothiazide.
Ferreira O; Mota A; Morais P; Cunha AP; Azevedo F
Cutan Ocul Toxicol; 2010 Dec; 29(4):293-5. PubMed ID: 20522001
[TBL] [Abstract][Full Text] [Related]
13. Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) induced by omeprazole.
Kardaun SH; Tupker RA
Int J Dermatol; 2012 Sep; 51(9):1134-7. PubMed ID: 21470217
[No Abstract] [Full Text] [Related]
14. First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?
Allain-Veyrac G; Lebreton A; Collonnier C; Jolliet P
Am J Clin Dermatol; 2011 Jun; 12(3):210-3. PubMed ID: 21469764
[TBL] [Abstract][Full Text] [Related]
15. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature.
Nespoulous L; Matei I; Charissoux A; Bédane C; Assikar S
Contact Dermatitis; 2018 Dec; 79(6):378-380. PubMed ID: 30062790
[No Abstract] [Full Text] [Related]
16. Co-occurrence of Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) and Pigmented Fixed Drug Eruption (FDE) in a Single Patient Due to Doxycycline: A Case Report.
Sahu K; Sirka CS; Pradhan S; Rout AN
Indian Dermatol Online J; 2020; 11(1):62-64. PubMed ID: 32055511
[TBL] [Abstract][Full Text] [Related]
17. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by oral metronidazole.
Şikar Aktürk A; Bayramgürler D; Salman S; Yıldız KD; Odyakmaz Demirsoy E
Cutan Ocul Toxicol; 2014 Dec; 33(4):337-8. PubMed ID: 24938451
[TBL] [Abstract][Full Text] [Related]
18. SDRIFE (baboon syndrome) due to paracetamol: case report.
Lugović-Mihić L; Duvančić T; Vučić M; Situm M; Kolić M; Mihić J
Acta Dermatovenerol Croat; 2013; 21(2):113-7. PubMed ID: 24001419
[TBL] [Abstract][Full Text] [Related]
19. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.
Kirven RM; Fisher K; Kaffenberger BH; Chung CG; Korman AM
Arch Dermatol Res; 2024 May; 316(6):279. PubMed ID: 38796524
[TBL] [Abstract][Full Text] [Related]
20. Systemic drug-related intertriginous and flexural exanthema (SDRIFE).
Elmariah SB; Cheung W; Wang N; Kamino H; Pomeranz MK
Dermatol Online J; 2009 Aug; 15(8):3. PubMed ID: 19891911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
